Categories AlphaGraphs, Earnings, Health Care

Biogen (BIIB) Q2 2024 Earnings: Key financials and quarterly highlights

Biogen Inc. (NASDAQ: BIIB) reported its second quarter 2024 earnings results today.

Total revenue of $2.5 billion was flat at actual currency and up 1% at constant currency compared to the same period a year ago.

Net income attributable to Biogen Inc. was $583.6 million compared to $591.6 million last year.

GAAP EPS dropped 2% to $4.00 while adjusted EPS rose 31% to $5.28 compared to last year.

For the full year of 2024, the company expects total revenue to decline by a low-single digit percentage. Adjusted EPS is expected to be $15.75-16.25.

Prior performance

Biogen Q1 2024 earnings infographic

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Key takeaways from Kroger’s (KR) Q1 2025 earnings report

The Kroger Co. (NYSE: KR) recently reported mixed results for the first quarter of fiscal 2025, with earnings beating estimates and sales missing. The grocery giant’s stock rose following the

What to expect when McCormick & Company (MKC) reports Q2 2025 earnings results

Shares of McCormick & Company, Incorporated (NYSE: MKC) gained over 1% on Monday. The stock has dropped 7% over the past three months. The condiments maker is slated to report its second

Earnings Preview: Paychex (PAYX) looks set to end FY25 on a strong note

Paychex Inc. (NASDAQ: PAYX) has benefited from the stable labor market and resilient customers, despite inflationary pressures and the challenging economic environment. The company is leveraging its strong fundamentals and

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top